Pharma

- Advertisement -
Ad imageAd image
UCB Expands CRM Capabilities With Veeva Vault

UCB has implemented the Veeva Vault CRM agentic CRM platform to meet its global customer engagement needs. This will enable UCB to deliver more consistent engagement across markets and also…

UCB Expands CRM Capabilities With Veeva Vault

UCB has implemented the Veeva Vault CRM agentic CRM platform to meet…

Rhythm and LG Chem Expand Bivamelagon Licensing Deal

Rhythm Pharmaceuticals and LG Chem have changed their global licensing agreement for…

HUTCHMED Wins FDA Orphan Drug Status for Sovleplenib

The US Food and Drug Administration has given Orphan Drug Designation to…

Ken Suzuki Joins Accenture as Principle Director for Life Sciences

Ken Suzuki has joined Accenture as Principle Director, Industry and Enterprise, Life…

Rhythm Pharmaceuticals Launches IM CIVREE in Japan for Hypothalamic Obesity

Rhythm Pharmaceuticals is now selling IM CIVREE in Japan. The drug contains…

Zealand Pharma and Generate Biomedicines Partner on AI-Designed Metabolic Disease Treatments

Zealand Pharma and Generate Biomedicines have entered a collaboration to develop AI‑engineered…

Zeal Launches MEDSCOPE for OTC Pharma Data Analysis

ZEAL, a DX company inside the Avant Group has introduced "MEDSCOPE," a…

SOLA Biosciences Japan Secures ¥6B Grant for ALS Gene Therapy

SOLA Biosciences Japan GK, the branch of the Boston-based company SOLA Biosciences…

UCB Expands CRM Capabilities With Veeva Vault

UCB has implemented the Veeva Vault CRM agentic CRM platform to meet…

Rhythm and LG Chem Expand Bivamelagon Licensing Deal

Rhythm Pharmaceuticals and LG Chem have changed their global licensing agreement for…

HUTCHMED Wins FDA Orphan Drug Status for Sovleplenib

The US Food and Drug Administration has given Orphan Drug Designation to…

Ken Suzuki Joins Accenture as Principle Director for Life Sciences

Ken Suzuki has joined Accenture as Principle Director, Industry and Enterprise, Life…

Rhythm Pharmaceuticals Launches IM CIVREE in Japan for Hypothalamic Obesity

Rhythm Pharmaceuticals is now selling IM CIVREE in Japan. The drug contains…

Zealand Pharma and Generate Biomedicines Partner on AI-Designed Metabolic Disease Treatments

Zealand Pharma and Generate Biomedicines have entered a collaboration to develop AI‑engineered…

Zeal Launches MEDSCOPE for OTC Pharma Data Analysis

ZEAL, a DX company inside the Avant Group has introduced "MEDSCOPE," a…

SOLA Biosciences Japan Secures ¥6B Grant for ALS Gene Therapy

SOLA Biosciences Japan GK, the branch of the Boston-based company SOLA Biosciences…

- Advertisement -
Ad imageAd image

Join Our Community

Join Our Community